228 related articles for article (PubMed ID: 24447533)
1. Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.
Sanchez AM; DeMarco CT; Hora B; Keinonen S; Chen Y; Brinkley C; Stone M; Tobler L; Keating S; Schito M; Busch MP; Gao F; Denny TN
J Immunol Methods; 2014 Jul; 409():117-30. PubMed ID: 24447533
[TBL] [Abstract][Full Text] [Related]
2. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).
Todd CA; Sanchez AM; Garcia A; Denny TN; Sarzotti-Kelsoe M
J Immunol Methods; 2014 Jul; 409():91-8. PubMed ID: 24120573
[TBL] [Abstract][Full Text] [Related]
3. Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.
Sambor A; Garcia A; Berrong M; Pickeral J; Brown S; Rountree W; Sanchez A; Pollara J; Frahm N; Keinonen S; Kijak GH; Roederer M; Levine G; D'Souza MP; Jaimes M; Koup R; Denny T; Cox J; Ferrari G
J Immunol Methods; 2014 Jul; 409():107-16. PubMed ID: 24787274
[TBL] [Abstract][Full Text] [Related]
4. The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.
Sarzotti-Kelsoe M; Needham LK; Rountree W; Bainbridge J; Gray CM; Fiscus SA; Ferrari G; Stevens WS; Stager SL; Binz W; Louzao R; Long KO; Mokgotho P; Moodley N; Mackay M; Kerkau M; McMillion T; Kirchherr J; Soderberg KA; Haynes BF; Denny TN
J Immunol Methods; 2014 Jul; 409():21-30. PubMed ID: 24910414
[TBL] [Abstract][Full Text] [Related]
5. Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.
Ducar C; Smith D; Pinzon C; Stirewalt M; Cooper C; McElrath MJ; Hural J;
J Immunol Methods; 2014 Jul; 409():9-20. PubMed ID: 24709391
[TBL] [Abstract][Full Text] [Related]
6. Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays.
Staats JS; Enzor JH; Sanchez AM; Rountree W; Chan C; Jaimes M; Chan RC; Gaur A; Denny TN; Weinhold KJ
J Immunol Methods; 2014 Jul; 409():44-53. PubMed ID: 24968072
[TBL] [Abstract][Full Text] [Related]
7. Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.
Sanchez AM; Denny TN; O'Gorman M
J Immunol Methods; 2014 Jul; 409():1-5. PubMed ID: 24910413
[TBL] [Abstract][Full Text] [Related]
8. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.
Lynch HE; Sanchez AM; D'Souza MP; Rountree W; Denny TN; Kalos M; Sempowski GD
J Immunol Methods; 2014 Jul; 409():62-71. PubMed ID: 24801479
[TBL] [Abstract][Full Text] [Related]
9. Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs.
Garcia A; Keinonen S; Sanchez AM; Ferrari G; Denny TN; Moody MA
J Immunol Methods; 2014 Jul; 409():99-106. PubMed ID: 24928650
[TBL] [Abstract][Full Text] [Related]
10. Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.
Rountree W; Vandergrift N; Bainbridge J; Sanchez AM; Denny TN
J Immunol Methods; 2014 Jul; 409():72-81. PubMed ID: 24456626
[TBL] [Abstract][Full Text] [Related]
11. The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.
Sanchez AM; Rountree W; Berrong M; Garcia A; Schuetz A; Cox J; Frahm N; Manak M; Sarzotti-Kelsoe M; D'Souza MP; Denny T; Ferrari G
J Immunol Methods; 2014 Jul; 409():31-43. PubMed ID: 24685833
[TBL] [Abstract][Full Text] [Related]
12. The Immunology Quality Assessment Proficiency Testing Program for CD3⁺4⁺ and CD3⁺8⁺ lymphocyte subsets: a ten year review via longitudinal mixed effects modeling.
Bainbridge J; Wilkening CL; Rountree W; Louzao R; Wong J; Perza N; Garcia A; Denny TN
J Immunol Methods; 2014 Jul; 409():82-90. PubMed ID: 24911327
[TBL] [Abstract][Full Text] [Related]
13. Setting objective thresholds for rare event detection in flow cytometry.
Richards AJ; Staats J; Enzor J; McKinnon K; Frelinger J; Denny TN; Weinhold KJ; Chan C
J Immunol Methods; 2014 Jul; 409():54-61. PubMed ID: 24727143
[TBL] [Abstract][Full Text] [Related]
14. Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.
Naarding MA; Fernandez N; Kappes JC; Hayes P; Ahmed T; Icyuz M; Edmonds TG; Bergin P; Anzala O; Hanke T; Clark L; Cox JH; Cormier E; Ochsenbauer C; Gilmour J
J Immunol Methods; 2014 Jul; 409():161-73. PubMed ID: 24291126
[TBL] [Abstract][Full Text] [Related]
15. The role of the reporting framework MIATA within current efforts to advance immune monitoring.
Janetzki S; Britten CM;
J Immunol Methods; 2014 Jul; 409():6-8. PubMed ID: 24816466
[No Abstract] [Full Text] [Related]
16. Pilot studies for development of an HIV subtype panel for surveillance of global diversity.
Manak M; Sina S; Anekella B; Hewlett I; Sanders-Buell E; Ragupathy V; Kim J; Vermeulen M; Stramer SL; Sabino E; Grabarczyk P; Michael N; Peel S; Garrett P; Tovanabutra S; Busch MP; Schito M
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):594-606. PubMed ID: 22149143
[TBL] [Abstract][Full Text] [Related]
17. Identification, Genetic Characterization and Validation of Highly Diverse HIV-1 Viruses for Reference Panel Development.
Zhao J; Huang H; Lee S; Ragupathy V; Biswas S; Mbondji-Wonje C; Wang X; Jiang A; Hewlett I
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372623
[TBL] [Abstract][Full Text] [Related]
18. Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites.
Hora B; Keating SM; Chen Y; Sanchez AM; Sabino E; Hunt G; Ledwaba J; Hackett J; Swanson P; Hewlett I; Ragupathy V; Vikram Vemula S; Zeng P; Tee KK; Chow WZ; Ji H; Sandstrom P; Denny TN; Busch MP; Gao F;
PLoS One; 2016; 11(6):e0157340. PubMed ID: 27314585
[TBL] [Abstract][Full Text] [Related]
19. Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China.
Han J; Liu S; Guo W; Bao Z; Wang X; Li L; Liu Y; Zhuang D; Li H; Jia L; Gui T; Sui H; Li T; Li J
PLoS One; 2015; 10(5):e0127696. PubMed ID: 26018591
[TBL] [Abstract][Full Text] [Related]
20. Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.
Brown BK; Darden JM; Tovanabutra S; Oblander T; Frost J; Sanders-Buell E; de Souza MS; Birx DL; McCutchan FE; Polonis VR
J Virol; 2005 May; 79(10):6089-101. PubMed ID: 15857994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
